Search by Drug Name or NDC

    NDC 66302-0014-01 Unituxin 3.5 mg/mL Details

    Unituxin 3.5 mg/mL

    Unituxin is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by United Therapeutics Corporation. The primary component is DINUTUXIMAB.

    Product Information

    NDC 66302-0014
    Product ID 66302-014_292edc42-e0de-40b2-be38-aadc411b1c88
    Associated GPIs 21356028002020
    GCN Sequence Number 074093
    GCN Sequence Number Description dinutuximab VIAL 3.5 MG/ML INTRAVEN
    HIC3 V1K
    HIC3 Description ANTINEOPLASTICS ANTIBODY/ANTIBODY-DRUG COMPLEXES
    GCN 38638
    HICL Sequence Number 042038
    HICL Sequence Number Description DINUTUXIMAB
    Brand/Generic Brand
    Proprietary Name Unituxin
    Proprietary Name Suffix n/a
    Non-Proprietary Name DINUTUXIMAB
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 3.5
    Active Ingredient Units mg/mL
    Substance Name DINUTUXIMAB
    Labeler Name United Therapeutics Corporation
    Pharmaceutical Class Glycolipid Disialoganglioside-directed Antibody Interactions [MoA], Glycolipid Disialoganglioside-directed Antibody [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125516
    Listing Certified Through 2024-12-31

    Package

    NDC 66302-0014-01 (66302001401)

    NDC Package Code 66302-014-01
    Billing NDC 66302001401
    Package 1 VIAL, SINGLE-DOSE in 1 BOX (66302-014-01) / 5 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2015-03-10
    NDC Exclude Flag N
    Pricing Information N/A